Friday, March 7, 2025

The Methamphetamine Epidemic: Evidence for Addressing the Issue

Richard Channick, MD

Meth-PAH: Pathophysiology and Genetic Contributions

Vinicio de Jesus Perez, MD

Managing Methamphetamine Substance Use Disorder

Michael Incze, MD

Collaborative Care Models

Katharine Clapham, MD

Panel Discussion | Audience Q&A

Moderator: Eleni Tseliou, MD
Discussants: Richard Channick, MD;
Vinicio de Jesus Perez, MD; Michael Incze, MD;
Katharine Clapham, MD

Diverse Populations and Access to Care

Lana Melendres-Groves, MD

Understanding Inequities in Access to Lung Transplantation for Patients with PAH

Nicholas Kolaitis, MD, MAS

Regional Variations in PAH in the US

Peter Leary, MD, PhD

Panel Discussion | Audience Q&A

Moderator: Mrinalini Krishnan, MD
Discussants: Lana Melendres-Groves, MD;
Nicholas Kolaitis, MD, MAS
Peter Leary, MD, PhD

CTEPH Update

• Genetics of CTEPH

Mark Dodson, MD, PhD

• Management of CTEPH

Josanna Rodriguez-Lopez, MD

ILD-PH: Current Therapies and Pathways of Interest

Rajan Saggar, MD

Panel Discussion | Audience Q&A

Moderator: Richard Channick, MD
Discussants: Mark Dodson, MD, PhD;
Josanna Rodriguez-Lopez, MD; Rajan Saggar, MD

Risk Assessment in PAH

Sophia Airhart, MD

Recent Advances in Treatment for Pulmonary Hypertension

Ronald Zolty, MD, PhD

Antiproliferative Therapies

Naomi Habib, MD

Panel Discussion | Audience Q&A

Moderator: Jean Elwing, MD, FCCP
Discussants: Sophia Airhart, MD;
Ronald Zolty, MD, PhD;
Naomi Habib, MD